PP
KERX

Paloma Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Paloma Partners’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-80,936
Closed -$536K – 2301
2016
Q2 		$536K Buy
+80,936
New +$453K 0.01% 1506
2016
Q1 		– Sell
-21,158
Closed -$107K – 2177
2015
Q4 		$107K Buy
21,158
+9,884
+88% +$47K ﹤0.01% 1604
2015
Q3 		$40K Buy
+11,274
New +$75.5K ﹤0.01% 1564
2014
Q4 		– Sell
-40,000
Closed -$550K – 1480
2014
Q3 		$550K Buy
40,000
+20,085
+101% +$307K 0.03% 503
2014
Q2 		$306K Buy
+19,915
New +$282K 0.01% 789

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Paloma Partners's KERX Position: Q3 2016 in Review

Paloma Partners sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2016, closing a stake of 80,936 shares — an estimated $536K sold.

Paloma Partners first reported a position in KERX in Q2 2014 and held it in 5 quarters. The position peaked at $550K in Q3 2014. 116 funds tracked by Wall St. Rank hold KERX as of Q3 2016.

  • Paloma Partners reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Paloma Partners sold 80,936 Keryx Biopharmaceuticals Inc shares in Q3 2016, an estimated $536K.
  • Paloma Partners first reported a position in Keryx Biopharmaceuticals Inc in Q2 2014 and held it in 5 quarters.
  • Paloma Partners's Keryx Biopharmaceuticals Inc position peaked at $550K in Q3 2014.
  • 116 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.